Drug Profile
SB 242235
Latest Information Update: 27 Mar 2001
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Imidazoles; Pyridines
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis